/

In

VCRO express

VCRO express

Great news! TFDA has approved Phase III clinical trials for the use of BNCT in the treatment of rGBM with small molecule pharmaceuticals.

•

Aug 25
VCRO express

Congratulations! A recombinant protein medicine for diabetic wound treatment has received TFDA approval for Phase II clinical trials!

•

Jun 9
VCRO express

Congratulations! A new nasal spray drug for asthma treatment has been approved by the TFDA to proceed with the IIT phase II clinical trial

•

Apr 26
VCRO express

Congratulations! Allogeneic stem cell for cardiovascular disease treatment has received TFDA approval for Phase I clinical trial!

•

Mar 10
VCRO express

Congratulation! An ODD application for heterologous CAR-T product was granted by FDA!

•

Feb 18
VCRO express

Congratulation! An ODD application for autologous CAR-T product was granted by EMA!

•

Dec 14
VCRO express

Congratulation! TCR-T Cells therapy to treat Solid Tumor was granted by the US FDA IND!

•

Jul 4
VCRO express

Virginia Contract Research Organization (Shanghai) partners with strategy consulting firms to create a one-stop shop for clinical development

•

Aug 10
VCRO express

Congratulation! A cell therapy for adjuvant immunotherapy to treat lung cancer was granted by the US FDA IND!

•

Feb 20
VCRO express

Congratulation! A cell therapy for adjuvant immunotherapy was granted by the US FDA!

•

Dec 22